Accidental Overdose of Paliperidone Palmitate
Long-acting injectable (LAI) antipsychotics first introduced in 1960s are useful in the treatment of schizophrenic patients with poor medication adherence due to their maintaining feature of therapeutic plasma level without daily administration. Paliperidone Palmitate is one of such LAI antipsychoti...
Saved in:
| Main Authors: | Chiedozie Ojimba, Ayotomide Oyelakin, Taher Khandaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2019/7406298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Paliperidone Palmitate on Coagulation: An Experimental Study
by: Enver Demirel Yılmaz, et al.
Published: (2014-01-01) -
Gender-stratified 9-month comparison of paliperidone extended-release tablets and paliperidone palmitate injection in schizophrenia
by: Zheng Lan, et al.
Published: (2025-05-01) -
Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
by: Kadir Demirci, et al.
Published: (2015-01-01) -
Patient social function and quality of life in schizophrenia: focus on paliperidone palmitate
by: E. V. Grigorieva
Published: (2018-07-01) -
Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia
by: Gihan Elsisi, et al.
Published: (2023-08-01)